TO EVALUATE THE SHORT TERM EFFICACY AND SAFETY OF INTRAVITREAL BEVACIZUMAB IN TREATMENT OF DIABETIC MACULAR EDEMA AND TO COMPARE IT WITH CONVENTIONAL LASER THERAPY AS A PRIMARY THERAPY. - Current Issue

TO EVALUATE THE SHORT TERM EFFICACY AND SAFETY OF INTRAVITREAL BEVACIZUMAB IN TREATMENT OF DIABETIC MACULAR EDEMA AND TO COMPARE IT WITH CONVENTIONAL LASER THERAPY AS A PRIMARY THERAPY. - Current Issue - IJSR